Clinical Significance of Histone Demethylase NO66 in Invasive Colorectal Cancer
Authors:
- 29 July 2016
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 24 (3) , 841-849
Abstract
Targeting epigenetic regulators is a promising therapeutic strategy against cancer. However, because of the broad spectrum of targets, selective inhibitionKeywords
Funding Information
- Chugai Co., Ltd.
- Evidence Based Medical (EBM) Research Center
- Yakult Honsha Co., Ltd.
- Ministry of Health, Labor and Welfare
- Merck Co., Ltd.
- Unitech Co., Ltd.
- Ministry of Education, Culture, Sports, Science and Technology
- Osaka University Drug Discovery Funds
- National Institute of Biomedical Innovation
- Taiho Pharmaceutical Co., Ltd.
This publication has 30 references indexed in Scilit:
- Histone lysine demethylases as targets for anticancer therapyNature Reviews Drug Discovery, 2013
- Clinical implications of the LINE-1 methylation levels in patients with gastrointestinal cancerSurgery Today, 2013
- Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances TumorigenicityCell, 2013
- MicroRNAs in cancer diagnosis and therapy: from bench to bedsideSurgery Today, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Regulation of Pancreatic Tumor Cell Proliferation and Chemoresistance by the Histone Methyltransferase Enhancer of Zeste Homologue 2Clinical Cancer Research, 2008
- 5-Azacytidine, a DNA methyltransferase inhibitor, induces ATR-mediated DNA double-strand break responses, apoptosis, and synergistic cytotoxicity with doxorubicin and bortezomib against multiple myeloma cellsMolecular Cancer Therapeutics, 2007
- DNA methylation and histone modification regulate silencing of epithelial cell adhesion molecule for tumor invasion and progressionOncogene, 2007
- Global histone modification patterns predict risk of prostate cancer recurrenceNature, 2005
- Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancerNature Genetics, 2005